Hyperthyroidism and cardiovascular disease: an association study using big data analytics.
Atrial fibrillation
Diabetes mellitus
Dyslipidemia
Hypertension
Hyperthyroidism
Smoking habit
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
15 Aug 2023
15 Aug 2023
Historique:
received:
11
04
2023
accepted:
04
08
2023
medline:
15
8
2023
pubmed:
15
8
2023
entrez:
15
8
2023
Statut:
aheadofprint
Résumé
The cardiovascular (CV) system is profoundly affected by thyroid hormones. Both hypo- and hyperthyroidism can increase the risk of severe CV complications. To assess the association of hyperthyroidism with major CV risk factors (CVRFs) and CV diseases (CVDs) using a big data methodology with the Savana Manager platform. This was an observational and retrospective study. The data were obtained from the electronic medical records of the University Hospital Puerta de Hierro Majadahonda (Spain). Artificial intelligence techniques were used to extract the information from the electronic health records and Savana Manager 3.0 software was used for analysis. Of a total of 540,939 patients studied (53.62% females; mean age 42.2 ± 8.7 years), 5504 patients (1.02%; 69.9% women) had a diagnosis of hyperthyroidism. Patients with this diagnosis had a significantly (p < 0.0001) higher frequency of CVRFs than that found in non-hyperthyroid subjects. The higher frequency of CVRFs in patients with hyperthyroidism was observed in both women and men and in patients younger and older than 65 years of age. The total frequency of CVDs was also significantly (p < 0.0001) higher in patients diagnosed with hyperthyroidism than that found in patients without this diagnosis. The highest odds ratio values obtained were 6.40 (4.27-9.61) for embolic stroke followed by 5.99 (5.62-6.38) for atrial fibrillation. The frequency of all CVDs evaluated in patients with a diagnosis of hyperthyroidism was significantly higher in both women and men, as well as in those younger and older than 65 years, compared to subjects without this diagnosis. A multivariate regression analysis showed that hyperthyroidism was significantly and independently associated with all the CVDs evaluated except for embolic stroke. The data from this hospital cohort suggest that there is a significant association between the diagnosis of hyperthyroidism and the main CVRFs and CVDs in our population, regardless of the age and gender of the patients. Our study, in addition to confirming this association, provides useful information for understanding the applicability of artificial intelligence techniques to "real-world data and information".
Sections du résumé
BACKGROUND
BACKGROUND
The cardiovascular (CV) system is profoundly affected by thyroid hormones. Both hypo- and hyperthyroidism can increase the risk of severe CV complications.
OBJECTIVE
OBJECTIVE
To assess the association of hyperthyroidism with major CV risk factors (CVRFs) and CV diseases (CVDs) using a big data methodology with the Savana Manager platform.
MATERIAL AND METHODS
METHODS
This was an observational and retrospective study. The data were obtained from the electronic medical records of the University Hospital Puerta de Hierro Majadahonda (Spain). Artificial intelligence techniques were used to extract the information from the electronic health records and Savana Manager 3.0 software was used for analysis.
RESULTS
RESULTS
Of a total of 540,939 patients studied (53.62% females; mean age 42.2 ± 8.7 years), 5504 patients (1.02%; 69.9% women) had a diagnosis of hyperthyroidism. Patients with this diagnosis had a significantly (p < 0.0001) higher frequency of CVRFs than that found in non-hyperthyroid subjects. The higher frequency of CVRFs in patients with hyperthyroidism was observed in both women and men and in patients younger and older than 65 years of age. The total frequency of CVDs was also significantly (p < 0.0001) higher in patients diagnosed with hyperthyroidism than that found in patients without this diagnosis. The highest odds ratio values obtained were 6.40 (4.27-9.61) for embolic stroke followed by 5.99 (5.62-6.38) for atrial fibrillation. The frequency of all CVDs evaluated in patients with a diagnosis of hyperthyroidism was significantly higher in both women and men, as well as in those younger and older than 65 years, compared to subjects without this diagnosis. A multivariate regression analysis showed that hyperthyroidism was significantly and independently associated with all the CVDs evaluated except for embolic stroke.
CONCLUSION
CONCLUSIONS
The data from this hospital cohort suggest that there is a significant association between the diagnosis of hyperthyroidism and the main CVRFs and CVDs in our population, regardless of the age and gender of the patients. Our study, in addition to confirming this association, provides useful information for understanding the applicability of artificial intelligence techniques to "real-world data and information".
Identifiants
pubmed: 37581746
doi: 10.1007/s12020-023-03482-9
pii: 10.1007/s12020-023-03482-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
I. Klein, K. Ojamaa, Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501–509 (2001)
pubmed: 11172193
doi: 10.1056/NEJM200102153440707
S. Fazio, E.A. Palmieri, G. Lombardi, B. Biondi, Effects of thyroid hormone on the cardiovascular system. Recent Prog. Horm. Res. 59, 31–50 (2004)
pubmed: 14749496
doi: 10.1210/rp.59.1.31
A. Jabbar, A. Pingitore, S.H. Pearce, A. Zaman, G. Iervasi, S. Razvi, Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 14, 39–55 (2017)
pubmed: 27811932
doi: 10.1038/nrcardio.2016.174
H. Vargas-Uricoechea, A. Bonelo-Perdomo, C.H. Sierra-Torres, Effects of thyroid hormones on the heart. Clin. Investig. Arterioscler. 26, 296–309 (2014)
pubmed: 25438971
A. Abdel-Moneim, A.M. Gaber, S. Gouda, A. Osama, S.I. Othman, G. Allam, Relationship of thyroid dysfunction with cardiovascular diseases: updated review on heart failure progression. Hormones (Athens) 19, 301–309 (2020)
pubmed: 32488814
doi: 10.1007/s42000-020-00208-8
J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)
pubmed: 11836274
doi: 10.1210/jcem.87.2.8182
S. De Leo, S.Y. Lee, L.E. Braverman, Hyperthyroidism. Lancet. 388, 906–918 (2016)
pubmed: 27038492
doi: 10.1016/S0140-6736(16)00278-6
P.N. Taylor, D. Albrecht, A. Scholz, G. Gutierrez-Buey, J.H. Lazarus, C.M. Dayan, O.E. Okosieme, Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018)
pubmed: 29569622
doi: 10.1038/nrendo.2018.18
M. Hussein, E. Toraih, A.S.C. Reisner, P. Miller, R. Corsetti, E. Kandil, Prevalence and mortality of cardiovascular events in patients with hyperthyroidism: a nationwide cohort study in the United States. Gland Surg. 10, 2608–2621 (2021)
pubmed: 34733711
doi: 10.21037/gs-21-236
W.M. Wiersinga, K.G. Poppe, G. Effraimidis, Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 11, 282–298 (2023)
pubmed: 36848916
doi: 10.1016/S2213-8587(23)00005-0
J.L. Izquierdo, C. Almonacid, C. Campos, D. Morena, M. Benavent, D. González-de-Olano, J.M. Rodríguez,, Systemic corticosteroids in patients with bronchial asthma: a real-life study. J. Investig. Allergol. Clin. Immunol. (2021). https://doi.org/10.18176/jiaci.0765 .
J.L. Izquierdo, C. Almonacid, Y. González, C. Del Rio-Bermudez, J. Ancochea, R. Cárdenas, S. Lumbreras, J.B. Soriano, The impact of COVID-19 on patients with asthma. Eur. Respir. J. 57, 2003142 (2021). https://doi.org/10.1183/13993003.03142-2020
doi: 10.1183/13993003.03142-2020
pubmed: 33154029
D. Morena, J. Fernández, C. Campos, M. Castillo, G. López, M. Benavent, J.L. Izquierdo, Clinical profile of patients with idiopathic pulmonary fibrosis in real life. J. Clin. Med. 12, 1669 (2023). https://doi.org/10.3390/jcm12041669
doi: 10.3390/jcm12041669
pubmed: 36836204
I. Hernandez Medrano, C. Belda, A. Urena, I. Salcedo, L.T. Espinosa-Anke, H. Saggion, Savana: Reusing electronic health records with artificial intelligence. Int. J. Interact. Multimed. Artif. Intell. 4, 8–12 (2017)
L. Canales, S. Menke, S. Marchesseau, A. D’Agostino, C. del Rio-Bermudez, M. Taberna, J. Tello, Assessing the performance of clinical natural language processing systems: development of an evaluation methodology. JMIR Med. Inform. 9, e20492 (2021)
R.A. Baeza-Yates, B. Ribeiro-Neto, Modern Information Retrieval (Addison-Wesley Longman Publishing Co, Inc., Boston, 1999)
J.S. Neves, R. Fontes-Carvalho, M. Borges-Canha, A.R. Leite, M. von Hafe, C. Vale, S. Martins, J.T. Guimarães, D. Carvalho, A. Leite-Moreira, A. Azevedo, Association of thyroid function, within the euthyroid range, with cardiovascular risk: The EPIPorto study. Front. Endocrinol. (Lausanne). 13, 1067801 (2022)
pubmed: 36518251
doi: 10.3389/fendo.2022.1067801
P. Iglesias, J.J. Díez, Hyperthyroidism and cardiovascular risk factors: a nationwide study. Endocrinol. Diabetes Nutr. (Engl Ed.) 70, 255–261 (2023).
I. Saito, K. Ito, T. Saruta, The effect of age on blood pressure in hyperthyroidism. J. Am. Geriatr. Soc. 33, 19–22 (1985)
pubmed: 3965551
doi: 10.1111/j.1532-5415.1985.tb02854.x
F. Osman, J.A. Franklyn, R.L. Holder, M.C. Sheppard, M.D. Gammage, Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. J. Am. Coll. Cardiol. 49, 71–81 (2007)
pubmed: 17207725
doi: 10.1016/j.jacc.2006.08.042
S. Metso, A. Auvinen, J. Salmi, H. Huhtala, P. Jaatinen, Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clin. Endocrinol. (Oxf). 68, 450–457 (2008)
pubmed: 17941909
doi: 10.1111/j.1365-2265.2007.03064.x
E. Ryödi, J. Salmi, P. Jaatinen, H. Huhtala, R. Saaristo, M. Välimäki, A. Auvinen, S. Metso, Cardiovascular morbidity and mortality in surgically treated hyperthyroidism – a nation-wide cohort study with a long-term follow-up. Clin. Endocrinol. (Oxf). 80, 743–750 (2014)
pubmed: 24304446
doi: 10.1111/cen.12359
E. Ryödi, S. Metso, H. Huhtala, M. Välimäki, A. Auvinen, P. Jaatinen, Cardiovascular morbidity and mortality after treatment of hyperthyroidism with either radioactive iodine or thyroidectomy. Thyroid 28, 1111–1120 (2018)
pubmed: 29882483
doi: 10.1089/thy.2017.0461
E.N. Liberopoulos, M.S. Elisaf, Dyslipidemia in patients with thyroid disorders. Hormones (Athens) 1, 218–223 (2002)
pubmed: 17018450
doi: 10.14310/horm.2002.1170
M. Hage, M.S. Zantout, S.T. Azar, Thyroid disorders and diabetes mellitus. J. Thyroid Res. 2011, 439463 (2011)
pubmed: 21785689
doi: 10.4061/2011/439463
B. Biondi, G.J. Kahaly, R.P. Robertson, Thyroid dysfunction and diabetes mellitus: two closely associated disorders. Endocr. Rev. 40, 789–824 (2019)
pubmed: 30649221
doi: 10.1210/er.2018-00163
P. Perros, R.J. McCrimmon, G. Shaw, B.M. Frier, Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet. Med. 12, 622–627 (1995)
pubmed: 7554786
doi: 10.1111/j.1464-5491.1995.tb00553.x
J.J. Díez, P. Sánchez, P. Iglesias, Prevalence of thyroid dysfunction in patients with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 119, 201–207 (2011)
pubmed: 21465427
doi: 10.1055/s-0031-1271691
M. Nishi, Diabetes mellitus and thyroid diseases. Diabetol. Int. 9, 108–112 (2018)
pubmed: 30603357
doi: 10.1007/s13340-018-0352-4
K.E. Peters, S.A.P. Chubb, D.G. Bruce, W.A. Davis, T.M.E. Davis, Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II. Clin. Endocrinol. (Oxf). 92, 373–382 (2020)
pubmed: 31984536
doi: 10.1111/cen.14164
J.J. Díez, P. Iglesias, Subclinical hyperthyroidism in patients with type 2 diabetes. Endocrine. 42, 157–163 (2012)
pubmed: 22327927
doi: 10.1007/s12020-012-9621-3
J.J. Díez, P. Iglesias, Prevalence of diabetes in people with thyroid dysfunction. Med. Clin. (Barc). 160, 333–340 (2023).
P. Vestergaard, L. Rejnmark, J. Weeke, H.C. Hoeck, H.K. Nielsen, J. Rungby, P. Laurberg, L. Mosekilde, Smoking as a risk factor for Graves’ disease, toxic nodular goiter, and autoimmune hypothyroidism. Thyroid 12, 69–75 (2002)
pubmed: 11838733
doi: 10.1089/105072502753451995
W.M. Wiersinga, Smoking and thyroid. Clin. Endocrinol. (Oxf). 79, 145–151 (2013)
pubmed: 23581474
doi: 10.1111/cen.12222
S. Park, W.G. Kim, M.J. Jeon, M. Kim, H. Oh, M. Han, T.Y. Kim, Y.K. Shong, W.B. Kim, Serum thyroid-stimulating hormone levels and smoking status: data from the Korean National Health and Nutrition Examination Survey VI. Clin. Endocrinol. (Oxf). 88, 969–976 (2018)
pubmed: 29604104
doi: 10.1111/cen.13606
L. Frost, P. Vestergaard, L. Mosekilde, Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch. Intern. Med. 164, 1675–1678 (2004)
pubmed: 15302638
doi: 10.1001/archinte.164.15.1675
H. Bruere, L. Fauchier, A. Bernard Brunet, B. Pierre, E. Simeon, D. Babuty, N. Clementy, History of thyroid disorders in relation to clinical outcomes in atrial fibrillation. Am. J. Med. 128, 30–37 (2015)
pubmed: 25058863
doi: 10.1016/j.amjmed.2014.07.014
B. Gorenek, G. Boriani, G. Dan, L. Fauchier, G. Fenelon, H. Huang, G. Kudaiberdieva, G.Y.H. Lip, R. Mahajan, T. Potpara, J.D. Ramirez, M.A. Vos, F. Marin; ESC Scientific Document Group, European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). Europace 20, 895–896 (2018)
pubmed: 29566135
doi: 10.1093/europace/euy051
H.J. Kim, T. Kang, M.J. Kang, H.S. Ahn, S.Y. Sohn, Incidence and mortality of myocardial infarction and stroke in patients with hyperthyroidism: a nationwide cohort study in Korea. Thyroid 30, 955–965 (2020)
pubmed: 32093587
doi: 10.1089/thy.2019.0543
X. Jiang, H. Xing, J. Wu, R. Du, H. Liu, J. Chen, J. Wang, C. Wang, Y. Wu, Prognostic value of thyroid hormones in acute ischemic stroke – a meta analysis. Sci. Rep. 7, 16256 (2017)
L. Fani, O. Roa Dueñas, D. Bos, M.W. Vernooij, C.C.W. Klaver, M.K. Ikram, R.P. Peeters, M.A. Ikram, L. Chaker, Thyroid status and brain circulation: The Rotterdam Study. J. Clin. Endocrinol. Metab. 107, e1293–e1302 (2022)
pubmed: 34634119
doi: 10.1210/clinem/dgab744
S. Danzi, I. Klein, Thyroid disease and the cardiovascular system. Endocrinol. Metab. Clin. North Am. 43, 517–528 (2014)
pubmed: 24891175
doi: 10.1016/j.ecl.2014.02.005
C.H. Shih, S.L. Chen, C.C. Yen, Y.H. Huang, C.D. Chen, Y.S. Lee, K.H. Lin, Thyroid hormone receptor-dependent transcriptional regulation of fibrinogen and coagulation proteins. Endocrinology. 145, 2804–2814 (2004)
pubmed: 14977860
doi: 10.1210/en.2003-1372
J. Horacek, J. Maly, I. Svilias, L. Smolej, J. Cepkova, J. Vizda, P. Sadilek, I. Fatorova, P. Zak, Prothrombotic changes due to an increase in thyroid hormone levels. Eur. J. Endocrinol. 172, 537–542 (2015)
pubmed: 25637077
doi: 10.1530/EJE-14-0801
L.P.B. Elbers, E. Fliers, S.C. Cannegieter, The influence of thyroid function on the coagulation system and its clinical consequences. J. Thromb. Haemost. 16, 634–645 (2018)
pubmed: 29573126
doi: 10.1111/jth.13970
J.C. Liu, H.Y. Huang, Y.T. Hsu, Hyperthyroidism and thrombophilia in cerebral arterial and venous thrombosis: a case report and critical review. Neurologist 19, 53–55 (2015)
pubmed: 25607334
doi: 10.1097/NRL.0000000000000005
M. Yokoyama, R. Yamashita, M. Furuya, M. Yamazaki, K. Koyama, F. Tanaka, A case of cerebral venous thrombosis and deep venous thrombosis due to hyperthyroidism with increased factor VIII activity. J. Stroke Cerebrovasc. Dis. 28, 104364 (2019)
pubmed: 31521516
doi: 10.1016/j.jstrokecerebrovasdis.2019.104364
A. Kato, Y. Matsuo, A. Miyagaki, K. Endo, E. Hiraoka, Portal and mesenteric vein thrombosis associated with hyperthyroidism. Am. J. Case Rep. 22, e929565 (2021)
pubmed: 33819210
doi: 10.12659/AJCR.929565
T.Y. Kim, S.H. Ihm, J.W. Roh, S. Lim, C.S. Park, H.Y. Kim, Massive pulmonary thromboembolism combined with transient thyrotoxicosis in an 18 year old girl. Clin. Hypertens 26, 17 (2020).
F. Brandt, M. Thvilum, D. Almind, K. Christensen, A. Green, L. Hegedüs, T.H. Brix, Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study. PLoS One 8, e66711 (2013)
pubmed: 23818961
doi: 10.1371/journal.pone.0066711